menu

Podcasts

Beyond the Mic: Exploring the Journeys of Leaders.

View All Podcasts arrow

Cholestatic Pruritus Across the Age Spectrum: What Are You Missing?

When considering cholestatic pruritus across the age spectrum, a key point to remember is that while the underlying mechanism is similar, pediatric patients often present with unique challenges in diagnosis and management due to factors like limited communication abilities, potential side effects of medications, and the need for careful dosage adjustments; additionally, older adults might have co-morbidities that complicate treatment and require a more nuanced approach to managing pruritus

Podcasts

cardImg

HCV 101 - Confidently Treat HCV in any Setting
cardImg

Resmetirom: The First FDA-Approved Therapy for MASH
cardImg

Understanding Lipodystrophy – A Primer for Hepatologists
View All Podcasts arrow

Webcasts

cardImg

PBC Progression and Benefits of Early Diagnosis
cardImg

What is PBC?
cardImg

PBC Case Presentation With Dr. Brown
View All Webcasts arrow

Publications

View All Modules arrow
pcbimg

A practical approach to the diagnosis and management of hepatic encephalopathy
pcbimg

A practical approach to the diagnosis and management of hepatic encephalopathy
pcbimg

Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives

Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives
pcbimg

Clinicians and Patients Confront Practical Issues in Wilson Disease

Clinicians and Patients Confront Practical Issues in Wilson Disease

Abstract Library

Unlocking Boundless Knowledge Through Abstracts

View All Modules arrow
alcbimg

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study.

Della Corte Cristina (C);D'Amato Daphne (D);Rocchetti Adele (A);Martini Andrea (A);Morelli Maria Cristina (MC);Terracciani Francesca (F);Campigotto Michele (M);Pugliese Nicola (N);Pieri Giulia (G);Simone Loredana (L);Malinverno Federica (F);Degasperi Elisabetta (E);Reati Raffaella (R);Federico Alessandro (A);Gallo Raffaella (R);Colarossi Chiara (C);Svegliati-Baroni Gianluca (G);Morana Ester (E);Rapetti Rachele (R);Surace Lorenzo (L);Arena Ilaria (I);Perricone Giovanni (G);Ferrari Gianluca (G);Silano Marco (M);Torreri Paola (P);Invernizzi Pietro (P);Vespasiani-Gentilucci Umberto (U);Aghemo Alessio (A);Giannini Edoardo Giovanni (EG);Durante-Mangoni Emanuele (E);Missale Gabriele (G);Saibeni Simone (S);de Nucci Germana (G);Manes Giampiero (G);Viganò Mauro (M);Carbone Marco (M)

alcbimg

Reassessing Patient Selection and Clinical Endpoints in Terlipressin Therapy for HRS-AKI.

Yu Jianling (J);Yan Junbin (J)

alcbimg

Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.

Kuo Yuan-Hung (YH);Teng Wei (W);Lin Po-Ting (PT);Chen Yen-Hao (YH);Su Chung-Wei (CW);Shen Eric Yi-Liang (EY);Huang Bing-Shen (BS);Wu Tsung-Han (TH);Cheng Jen-Yu (JY);Hsieh Yi-Chung (YC);Chen Wei-Ting (WT);Hung Chao-Hung (CH);Lin Shi-Ming (SM);Lin Chen-Chun (CC);Wang Jing-Houng (JH);Lin Chun-Yen (CY)

alcbimg

Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological Diseases.

Heinrich Sophia (S);de Matos Andreia Margarida Carvalho (AMC);Colmenero Jordi (J);Elsharkawy Ahmed M (AM);Fraňková Soňa (S);Halbritter Jan (J);Mrzljak Anna (A);Müller Roman-Ulrich (RU);Pereira Rafaela (R);Strnad Pavel (P);Teemer Carmen A J (CAJ);Verbeek Jef (J);Wronka Karolina M (KM);Nevens Frederik (F);Taubert Richard (R);Drenth Joost P H (JPH); ()